📰 Prior Authorization News
Page 7 - Prior Authorization News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Prior Authorization. Real-time updates on events, politics, business and more.
January 9, 2024
The real-time, automated nature of green lighting offers precise control without the setbacks or manual efforts inherent to conventional gold carding programs. This innovative new approach also ensures adherence to state-level and other gold carding regulations
January 8, 2024
— Removal of Prior Authorization Upgrades Phexxi Coverage for Nearly 1.8 Million Washington Lives Across All Medicaid Plans — — Fans Encouraged to Plan for Victory, Prevent Unintended...
January 2, 2024
CMS made notable changes to the healthcare industry in 2023, affecting reimbursement, practice capabilities, and more.
December 29, 2023
Explore 10 moves that significantly impacted the cardiology space in 2023, from prior authorization updates to lawsuits and acquisitions.
December 20, 2023
Explore 5 major healthcare moves made by UnitedHealthcare Group, the largest health insurance company in the US.
December 18, 2023
Nearly half of physicians are equally excited and concerned about the use of AI in their field, according to a new AMA survey. Those who felt optimistic about AI cited reduced administrative burden as the number one benefit they’re seeking. Patient privacy and the impact to the patient-physician relationship were the most common reasons physicians cited for having reservations about AI.
December 15, 2023
Google leveraged its AI tools in 2023 to expand its healthcare presence with large health systems. Read more about Googles 5 biggest healthcare moves reported
December 14, 2023
The panelists offer practical tips on implementing HCV care into your clinical practice.
December 13, 2023
Cigna, the fourth-largest insurer in the US, has had an eventful year. Learn about 5 significant updates, from workforce reductions to Medicare Advantage fraud.
December 12, 2023
Key topics for patient-provider conversations within the biosimilar landscape are highlighted by expert panelists.